SEOM clinical guideline on hereditary colorectal cancer (2019)
Por:
Guillen-Ponce, C, Lastra, E, Lorenzo-Lorenzo, I, Gomez, T, Chamorro, R, Sanchez-Heras, A, Serrano, R, Rodriguez, M, Soto J and Robles, L
Publicada:
1 feb 2020
Ahead of Print:
1 ene 2020
Resumen:
In the last 2 decades, clinical genetics on hereditary colorectal syndromes has shifted from just a molecular characterization of the different syndromes to the estimation of the individual risk of cancer and appropriate risk reduction strategies. In the last years, new specific therapies for some subgroups of patients have emerged as very effective alternatives. At the same time, germline multigene panel testing by next-generation sequencing (NGS) technology has become the new gold standard for molecular genetics.
Filiaciones:
Guillen-Ponce, C:
Hosp Univ Ramon y Cajal, Med Oncol Dept, IRYCIS, Carretera Colmenar Viejo,Km 9,100, Madrid 28034, Spain
Lastra, E:
Hosp Univ Burgos, Med Oncol Dept, Burgos, Spain
Lorenzo-Lorenzo, I:
Complejo Hosp Univ Vigo CHUVI, Med Oncol Dept, Pontevedra, Spain
Gomez, T:
Hosp Univ Salamanca, Med Oncol Dept, Salamanca, Spain
Chamorro, R:
Hosp Gen La Mancha Ctr, Med Oncol Dept, Ciudad Real, Spain
:
Hosp Gen Univ Elche, Med Oncol Dept, Alicante, Spain
Serrano, R:
Hosp Univ Reina Sofia, Med Oncol Dept, CIBERONC, IMIBIC, Cordoba, Spain
Rodriguez, M:
Hosp Gen Virgen de la Luz, Med Oncol Dept, Cuenca, Spain
Soto J:
Hosp Gen Univ Elche, Mol Genet Lab, Alicante, Spain
Robles, L:
Hosp Univ Doce Octubre, Med Oncol Dept, Madrid, Spain
hybrid, Green Published
|